Publications

36
Results
(Filters Applied)
Nature. 2022 March 16.
A genome-scale screen for synthetic drivers of T cell proliferation.
Cell Reports. 2022 March 15.
The BTB transcription factors ZBTB11 and ZFP131 maintain pluripotency by repressing pro-differentiation genes.
Nature Reviews Cancer. 2022 Feb. 22.
CRISPR in cancer biology and therapy.
iScience. 2021 Oct. 29.
Automated design of CRISPR prime editors for thousands of human pathogenic variants.
Cell Genomics. 2021 Sept. 3.
Transcriptome-wide Cas13 guide RNA design for model organisms and viral RNA pathogens.
Genome Biology. 2021 Aug. 23.
Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.
Nature Reviews Molecular Cell Biology. 2021 Aug. 11.
Voices of the new generation: open science is good for science (and for you).
Cell Chemical Biology. 2021 Aug 2.
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.
Nature Biotechnology. 2021 May 19.
Tracking cell lineages to improve research reproducibility.
Nature Biotechnology 2021 Apr. 29.
Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens.
Genome Biology. 2021 Mar. 4.
Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity.
eLife. 2021 Feb. 11.
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Cell. 2020 Oct. 24.
Identification of required host factors for SARS-CoV-2 infection in human cells.
Nature Biotechnology. 2020 Mar. 16.
Massively parallel Cas13 screens reveal principles for guide RNA design.
Cell Reports. 2020 Mar. 3
High-Throughput Screens of PAM-Flexible Cas9 Variants for Gene Knockout and Transcriptional Modulation.
Stem Cell Research. 2019 Nov. 1.
Generation of a knock-in MAP2-tdTomato reporter human embryonic stem cell line with inducible expression of NEUROG2/1 (NYGCe001-A).
Nature Biomedical Engineering. 2019 Sep. 23.
Immunomagnetic cell sorting.
Cell Systems. 2019